×
About 6,400 results

ALLMedicine™ Prolactin Center

Research & Reviews  2,264 results

The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactino...
https://doi.org/10.1186/s12902-021-00900-9 10.1002/mgg3.1022 10.1007/s11102-005-5085-2 10.1007/s11102-019-00987-3 10.1007/s11102-009-0168-0 10.3389/fendo.2018.00768 10.1007/s11102-010-0237-4 10.1073/pnas.222319599 10.1159/000126764 10.3390/cancers11101618 10.1002/cncr.28864 10.1038/s41580-020-00322-w 10.1016/j.bbamcr.2007.03.010 10.1038/nrc2694 10.1016/j.ccr.2014.02.019 10.3390/ijms21176102 10.1016/j.tibs.2017.02.008 10.3748/wjg.v20.i29.9744 10.18632/oncotarget.7306 10.1038/srep13547 10.1111/jcmm.12718 10.1007/s10495-016-1223-8 10.3892/or.2017.5352 10.1074/jbc.M307591200 10.3389/fendo.2019.00330 10.1186/s12902-020-00619-z 10.1016/j.mce.2014.12.024 10.1016/S0303-7207(03)00236-3 10.1038/266640a0 10.1210/endo-107-4-1022 10.1210/endo-128-1-13 10.1159/000094308 10.1038/15275 10.1159/000014618 10.1177/019262339702500506 10.1055/s-0035-1546208 10.1016/j.pnpbp.2012.07.005 10.4158/EP-2018-0034 10.1677/erc.0.0080287 10.1007/s11102-013-0488-y 10.1210/jcem.85.9.6798 10.1530/EJE-14-0013 10.1159/000495775 10.2174/0929867320666131119155023 10.3390/ijms19082184 10.1111/jop.12707 10.1016/j.bbrc.2019.10.059 10.1016/j.phymed.2018.12.028 10.1186/1471-2407-8-375 10.3390/ijms21031102 10.1016/0014-5793(96)00255-4 10.1016/j.taap.2009.07.002 10.1074/jbc.273.12.6607 10.1172/JCI5257 10.1164/rccm.200207-664OC 10.1016/j.leukres.2006.11.006 10.1155/2020/3107290 10.1111/jcmm.13963 10.1016/j.bbrc.2019.09.070 10.1074/jbc.M202920200 10.1210/me.2013-1008 10.1159/000279753 10.1095/biolreprod62.6.1486
BMC Endocrine Disorders; Wang S, Wang A et. al.

Nov 25th, 2021 - Prolactinoma is a functional pituitary adenoma that secretes excessive prolactin. Dopamine agonists (DAs) such as bromocriptine (BRC) are the first-line treatment for prolactinomas, but the resistance rate is increasing year by year, creating a cl...

Understanding the Limitations of the Odds Ratio in a Case-Control Study of the Associat...
https://doi.org/10.4088/JCP.21f14319
The Journal of Clinical Psychiatry; Andrade C

Nov 24th, 2021 - Evidence suggests that women with schizophrenia are less likely to be screened for breast cancer, more likely to suffer from breast cancer, and more likely to die of breast cancer than women without schizophrenia or general population controls. An...

Baseline and stress-induced prolactin and corticosterone concentrations in a species wi...
https://doi.org/10.1016/j.ygcen.2021.113943
General and Comparative Endocrinology; Ledwoń M, Flis A et. al.

Nov 21st, 2021 - To understand the proximate mechanisms regulating brood desertion, we studied hormonal and behavioural stress responses during the chick-rearing period in adult Whiskered Terns (Chlidonias hybrida), a socially monogamous, semi-precocial species wi...

see more →

Guidelines  2 results

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for Pr...
https://doi.org/10.1227/NEU.0000000000001387
Neurosurgery Fleseriu M, Bodach ME et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present with hypopituitarism and/or hyperprolactinemia. To review the existing literature as it pertains to preoperative endocrine assessment in the work...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY DI...
https://doi.org/10.4158/EP15938.DSC
Endocrine Practice : Official Journal of the American Col... Samson SL, Hamrahian AH et. al.

Dec 8th, 2015 - To review the current literature regarding the prevalence of macroprolactin (macroPRL) in hyperprolactinemic patients and determine recommendations for testing. An electronic United States National Library of Medicine PubMed search (through Octobe...

see more →

Drugs  84 results see all →

Clinicaltrials.gov  85 results

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
https://clinicaltrials.gov/ct2/show/NCT03202303

Nov 8th, 2021 - There is a clear unmet need for new therapeutics to treat irritability in children with ASD that do not have the metabolic and weight adverse event profiles of the currently approved treatments. Cannabidivarin (CBDV) is a nonpsychoactive phytocann...

The Role of Estrogen in Luteinizing Hormone Surge and Ovulation
https://clinicaltrials.gov/ct2/show/NCT01999569

Nov 4th, 2021 - Sine the common understanding of ovulation in a natural cycle suggests that a sustained, elevated estradiol level is required to trigger the LH surge, administration of letrozole throughout the cycle should lower estradiol levels and prevent the L...

An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia
https://clinicaltrials.gov/ct2/show/NCT02640911

Sep 14th, 2021 - This multi-centre study will evaluate the safety and related factors study of atypical antipsychotics long-term treatment in Chinese Patients with Schizophrenia. The atypical antipsychotics include quetiapine, olanzapine, risperidone, aripiprazole...

Feasibility and Efficacy of rTMS in Healthy Persons
https://clinicaltrials.gov/ct2/show/NCT04074811

Sep 10th, 2021 - The short-term goal of this pilot project is to establish the feasibility and efficacy of repetitive transcranial magnetic stimulation (rTMS) on cognitive, behavioral, and physiological measures in a healthy community-recruited sample to plan long...

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
https://clinicaltrials.gov/ct2/show/NCT02288962

Sep 1st, 2021 - Due to lack of hormone overproduction in non-functioning pituitary adenomas (NFPAs), only the symptomatic adenomas or large adenomas with proven growth and risk for symptoms in near future will undergo pituitary surgery. The remaining adenomas are...

see more →

News  120 results

Biomarkers in Ovarian Cancer: Early Detection and Chemoresistance
https://www.onclive.com/view/biomarkers-in-ovarian-cancer-early-detection-and-chemoresistance

Oct 4th, 2021 - Abstract Ovarian cancer is a relatively rare but deadly disease. Biomarker panels for the detection of ovarian cancer are usually combined with screening for CA125, a known marker of ovarian cancer, and transabdominal or transvaginal ultrasonogr...

Trending Clinical Topic: Breast Cancer
https://www.medscape.com/viewarticle/959922

Oct 1st, 2021 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, share them with us on Twitter or Facebook. A slew of sig...

Antipsychotics Tied to Increased Breast Cancer Risk
https://www.medscape.com/viewarticle/958633

Sep 13th, 2021 - Use of antipsychotics that increase prolactin levels is significantly associated with an increased risk for breast cancer in women with schizophrenia, new research suggests. However, at least one expert says that at this point, clinical implicatio...

Repurposed Drug Flops in MS Trial, but Study Design Is Big Winner
https://www.medpagetoday.com/neurology/multiplesclerosis/91836

Mar 26th, 2021 - Repurposed domperidone was futile in a phase II secondary progressive multiple sclerosis (MS) trial, but the study may point to a novel way of evaluating generic drugs for MS treatment. A Simon two-stage futility trial of domperidone did not meet ...

Clozapine Still Underused in Refractory Schizophrenia
https://www.medscape.com/viewarticle/945771

Feb 12th, 2021 - With the exception of clozapine, the selection of an antipsychotic medication for acute treatment is driven by side effects. Dr Stephen Marder That's a key pearl of wisdom that Stephen R. Marder, MD, shared during a discussion of key criteria for ...

see more →

Patient Education  5 results see all →